Peter S. Kaufman, M.D.
Professor of Medicine, Hematology and Oncology
Director, Sponsored Clinical Research, University of Vermont Cancer Center
UVM Institutional PI, Alliance for Clinical Trials in Oncology
Given E214
89 Beaumont Ave
Burlington, VT 05405
United States
- M.D., New York University Grossman School of Medicine
- B.A., Biochemistry, Bowdoin College
Department of Medicine, Division of Hematology and Oncology
University of Vermont Cancer Center
BIO
Dr. Peter A. Kaufman is a Professor of Medicine at the Larner College of Medicine at UVM and a breast oncologist at the Universit of Vermont Medical Center. He serves as the Alliance for Clinical Trials in Oncology UVM Cancer Center Institutional Principal Investigator. He is an active clinician and clinical investigator, specializing in the care and treatment of patients with breast cancer. He is a leader in both clinical and translational research. He is a full member of the UVM Cancer Center, and collaborating in or overseeing numerous research studies in breast cancer. He has several primary areas of research interest, including HER-2 (+) breast cancer, and testing for and targeting HER-2/neu therapeutically, as well as novel therapies in HR+ breast cancer. His interests also include the development of new chemotherapeutic agents and approaches for patients with other subtypes of breast cancer breast cancer, and the development of novel targeted therapies for breast cancer, and translational research focused on the biologic and molecular basis of therapies for breast cancer. He has authored and co-authored numerous peer reviewed publications, and is an author on several early pivotal clinical trials evaluating Herceptin, and other novel targeted therapeutics. He is currently the study chair of a number of international, national and regional clinical trials in breast cancer. He additionally currently serves on the Breast Cancer Committee of the NCI sponsored Alliance for Clinical Trials in Oncology.
Dr. Kaufman's postdoctoral training
Fellowship, Duke University Medical Center - Hematology
Residency, Duke University Medical Center - Internal Medicine
Internship, Duke University Medical Center - Internal Medicine
Dr. Kaufman's professional associations
Publications
Bio
Dr. Peter A. Kaufman is a Professor of Medicine at the Larner College of Medicine at UVM and a breast oncologist at the Universit of Vermont Medical Center. He serves as the Alliance for Clinical Trials in Oncology UVM Cancer Center Institutional Principal Investigator. He is an active clinician and clinical investigator, specializing in the care and treatment of patients with breast cancer. He is a leader in both clinical and translational research. He is a full member of the UVM Cancer Center, and collaborating in or overseeing numerous research studies in breast cancer. He has several primary areas of research interest, including HER-2 (+) breast cancer, and testing for and targeting HER-2/neu therapeutically, as well as novel therapies in HR+ breast cancer. His interests also include the development of new chemotherapeutic agents and approaches for patients with other subtypes of breast cancer breast cancer, and the development of novel targeted therapies for breast cancer, and translational research focused on the biologic and molecular basis of therapies for breast cancer. He has authored and co-authored numerous peer reviewed publications, and is an author on several early pivotal clinical trials evaluating Herceptin, and other novel targeted therapeutics. He is currently the study chair of a number of international, national and regional clinical trials in breast cancer. He additionally currently serves on the Breast Cancer Committee of the NCI sponsored Alliance for Clinical Trials in Oncology.
Dr. Kaufman's postdoctoral training
Fellowship, Duke University Medical Center - Hematology
Residency, Duke University Medical Center - Internal Medicine
Internship, Duke University Medical Center - Internal Medicine
Dr. Kaufman's professional associations